Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Topped Off

<< Previous

Bullboard Posts

Next >>

Comment by rjc7on Feb 07, 2024 11:12am

133 Views

Post# 35867472

RE:RE:RE:Topped Off

You are correct. They have never issued release in advance. This is entirely new for them. I don't think we can read too much into it but it does seem to peak one's interest. Maybe they are tipping their hat somewhat.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant